Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01033565 · ClinicalTrials.gov registry record · Phase 4
Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders
A Phase 4 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT01033565 is a Phase 4 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 1 participants.
The verdict
NCT01033565, a Phase 4 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this research is to see the effects (good and bad) of Melatonin CR on sleep in 4-8 year old children with autism spectrum disorders and sleep problems.
Interventions
- DRUG Natrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-03-04 |
| Est. Completion | 2010-10-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01033565
The ClinicalTrials.gov registry entry for NCT01033565 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Natrol is the first listed.
NCT01033565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01033565 about?
NCT01033565 is a clinical study titled "Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders". The purpose of this research is to see the effects (good and bad) of Melatonin CR on sleep in 4-8 year old children with autism spectrum disorders and sleep problems.
What is the current status of trial NCT01033565?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2010-03-04. Estimated completion is 2010-10-01.
What interventions are being tested in trial NCT01033565?
The interventions under investigation include: Natrol (DRUG).
Who is sponsoring clinical trial NCT01033565?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.